BG40963A3 - Method for preparing 1, 3- disubstituted 2- oxyindols - Google Patents

Method for preparing 1, 3- disubstituted 2- oxyindols

Info

Publication number
BG40963A3
BG40963A3 BG068717A BG6871785A BG40963A3 BG 40963 A3 BG40963 A3 BG 40963A3 BG 068717 A BG068717 A BG 068717A BG 6871785 A BG6871785 A BG 6871785A BG 40963 A3 BG40963 A3 BG 40963A3
Authority
BG
Bulgaria
Prior art keywords
disubstituted
oxyindols
preparing
oxindoles
proven
Prior art date
Application number
BG068717A
Other languages
Bulgarian (bg)
English (en)
Inventor
Saul Kadin
Original Assignee
Pfizer Inc., a corporation organized аnd existing under the laws of the State of Delaware
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc., a corporation organized аnd existing under the laws of the State of Delaware filed Critical Pfizer Inc., a corporation organized аnd existing under the laws of the State of Delaware
Publication of BG40963A3 publication Critical patent/BG40963A3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/38—Oxygen atoms in positions 2 and 3, e.g. isatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
BG068717A 1984-02-07 1985-02-06 Method for preparing 1, 3- disubstituted 2- oxyindols BG40963A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57790384A 1984-02-07 1984-02-07

Publications (1)

Publication Number Publication Date
BG40963A3 true BG40963A3 (en) 1987-03-14

Family

ID=24310612

Family Applications (3)

Application Number Title Priority Date Filing Date
BG072172A BG43865A3 (en) 1984-02-07 1985-02-06 Method for preparing of 1, 3- disubstituted 2- oxyindols
BG068717A BG40963A3 (en) 1984-02-07 1985-02-06 Method for preparing 1, 3- disubstituted 2- oxyindols
BG072170A BG44204A3 (en) 1984-02-07 1985-02-06 Method for preparing of 2- oxyindol derivatives

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BG072172A BG43865A3 (en) 1984-02-07 1985-02-06 Method for preparing of 1, 3- disubstituted 2- oxyindols

Family Applications After (1)

Application Number Title Priority Date Filing Date
BG072170A BG44204A3 (en) 1984-02-07 1985-02-06 Method for preparing of 2- oxyindol derivatives

Country Status (14)

Country Link
US (1) US4658037A (pl)
JP (1) JPS60248669A (pl)
KR (2) KR880000433B1 (pl)
BG (3) BG43865A3 (pl)
CS (1) CS252480B2 (pl)
DD (2) DD234417A5 (pl)
HU (1) HU194166B (pl)
IN (1) IN163263B (pl)
MW (1) MW185A1 (pl)
PL (3) PL145230B1 (pl)
RO (2) RO90621A2 (pl)
YU (3) YU43866B (pl)
ZA (1) ZA85888B (pl)
ZM (1) ZM785A1 (pl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4721712A (en) * 1984-06-12 1988-01-26 Pfizer Inc. 1,3-disubstituted 2-oxindoles as analgesic and anti-inflammatory agents
US4808601A (en) * 1984-09-19 1989-02-28 Pfizer Inc. Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds
US4752609A (en) * 1985-06-20 1988-06-21 Pfizer Inc. Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds
HU215112B (hu) * 1989-01-10 1998-12-28 Pfizer Inc. Eljárás gyulladáscsökkentő 1-heteroaril-3-acil-2-oxindol-származékok előállítására
US4952703A (en) * 1989-05-25 1990-08-28 Pfizer Inc. Intermediates for making 2-oxindole-1-carboxamides
US5086186A (en) * 1989-05-25 1992-02-04 Pfizer Inc. N-trichloroacetyl-2-oxindole-1-carboxamides
US5298522A (en) * 1993-01-22 1994-03-29 Pfizer Inc. 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide as an analgesic and anti-inflammatory agent while maintaining a normal urine protein/creatinine ratio
ATE145206T1 (de) * 1993-02-09 1996-11-15 Pfizer Oxindol 1-(n-(alkoxycarbonyl)>carboxamide und 1- (n-carboxamido>carboxamide als antiinflammatorische wirkstoffe
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
EP2392258B1 (en) 2005-04-28 2014-10-08 Proteus Digital Health, Inc. Pharma-informatics system
US8795627B2 (en) 2007-03-21 2014-08-05 Raptor Pharmaceuticals Inc. Treatment of liver disorders by administration of RAP conjugates
JP2009040790A (ja) * 2008-08-29 2009-02-26 Ube Ind Ltd ５−フルオロオキシインドールの製造法
AU2010216512B2 (en) 2009-02-20 2016-06-30 2-Bbb Medicines B.V. Glutathione-based drug delivery system
WO2010129819A2 (en) 2009-05-06 2010-11-11 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN103570604B (zh) * 2012-07-21 2015-10-07 重庆圣华曦药业股份有限公司 齐拉西酮中间体的合成方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3462450A (en) * 1966-06-29 1969-08-19 Merck & Co Inc Chemical compounds
GB1158532A (en) * 1967-01-05 1969-07-16 Centre Nat Rech Scient 2-Oxoindoline-3-Carboxylic Acids and Esters thereof
US3519592A (en) * 1967-04-18 1970-07-07 Smithkline Corp Indole compounds
US3631177A (en) * 1967-04-18 1971-12-28 Smith Kline French Lab 3-phenacyl-2-oxoindolines
BE714717A (pl) * 1967-05-12 1968-09-30
FR7337M (pl) * 1968-01-11 1969-10-13
BE756447A (fr) * 1969-10-15 1971-03-22 Pfizer Oxindolecarboxamides
US3749731A (en) * 1971-07-08 1973-07-31 Warner Lambert Co 2-oxo-n-(2-thiazolyl)-3-indoline-carboxamide
US3975531A (en) * 1973-10-02 1976-08-17 A. H. Robins Company, Incorporated 4-(5- And 7-)benzoylindolin-2-ones and pharmaceutical uses thereof
US4221716A (en) * 1979-02-16 1980-09-09 A. H. Robins Company, Inc. Intermediate and process for the preparation of 7-acylindolin-2-ones

Also Published As

Publication number Publication date
RO93218A (ro) 1987-12-31
RO90621A2 (ro) 1986-12-10
JPS60248669A (ja) 1985-12-09
PL145196B1 (en) 1988-08-31
PL145230B1 (en) 1988-08-31
US4658037A (en) 1987-04-14
PL145310B1 (en) 1988-09-30
CS252480B2 (en) 1987-09-17
JPH0413340B2 (pl) 1992-03-09
YU46320B (sh) 1993-05-28
CS78585A2 (en) 1987-01-15
DD244133A5 (de) 1987-03-25
IN163263B (pl) 1988-08-27
YU43866B (en) 1989-12-31
KR850005824A (ko) 1985-09-26
RO93218B (ro) 1988-01-01
KR880000433B1 (ko) 1988-03-24
BG44204A3 (en) 1988-10-14
KR880000434B1 (ko) 1988-03-24
ZM785A1 (en) 1985-08-22
YU18085A (en) 1988-04-30
YU198187A (en) 1988-10-31
YU129087A (en) 1988-02-29
PL255465A1 (en) 1986-07-15
PL251869A1 (en) 1985-12-17
BG43865A3 (en) 1988-08-15
HU194166B (en) 1988-01-28
MW185A1 (en) 1986-04-09
DD234417A5 (de) 1986-04-02
YU44062B (en) 1990-02-28
ZA85888B (en) 1986-09-24

Similar Documents

Publication Publication Date Title
BG40814A3 (en) Method for preparing nucleozides
BG31645A3 (en) Method for obtaining of phenetanolamine
BG35189A3 (en) Method for preparing derivatives of 6- beta- hydroxyalkylpenicillanic acid
BG37995A3 (en) Method for preparing derivatives of 2- cyanbenzimidazol
BG37523A3 (en) Method for preparing peptides
BG38333A3 (en) Method for preparing substituted phenylcarboxyoximes
BG38487A3 (en) Method for preparing peptides
BG38334A3 (en) Method for preparing pyrolidinic derivatives
BG40963A3 (en) Method for preparing 1, 3- disubstituted 2- oxyindols
BG35328A3 (en) Method for preparing imidodisulphamidic derivatives
BG40815A3 (en) Method for preparing peptides
BG38163A3 (en) Method for preparing pyrimidones
BG36348A3 (en) Method for preparing thienopyridinon derivatives
BG41126A3 (en) Method for preparing benzamides
BG42355A3 (en) Method for preparing aminoguanidinic derivatives
BG37992A3 (en) Method for preparing derivatives of benzamide
BG35464A3 (en) Method preparing fluorene derivatives
BG37525A3 (en) Method for preparing n- substituted flavon- 8- carbonamides
BG40148A3 (en) Method for preparing heterocyclic compound
BG38638A3 (en) Method for preparing arylcyclobutyl- aminoderivatives
BG36935A3 (en) Method for preparing benzodiazepine compounds
BG36934A3 (en) Method for preparing sulphuric- containing isoquinolinic derivatives
BG36344A3 (en) Method for preparing 4- quinoline derivatives
BG37839A3 (en) Method for preparing derivatives of ortho- condensated pyrol
BG38338A3 (en) Method for preparing 6 alpha- methylhydrocortisonic derivatives